Browsing tre d'Esclerosi Múltiple de Catalunya

A plain language summary of what clinical studies can tell us about the safety of evobrutinib – a potential treatment for multiple sclerosis

wallace, daniel; Genovese, Mark C; Tomic, Davorka Lucia; Parsons-Rich, Dana; Bolay, Claire Le; Montalban, Xavier (Future Medicine, 2023-08)

A R-Script for Generating Multiple Sclerosis Lesion Pattern Discrimination Plots

Marschallinger, Robert; Tur Gomez, Carmen; Marschallinger, Hannes; Sellner, Johann (MDPI, 2021-01-12)

Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study

Midaglia Fernandez, Luciana; Mulero Carrillo, Patricia; Montalban Gairín, Xavier; Graves, Jennifer; Hauser, Stephen L.; Julian, Laura (JMIR Publications, 2019-08-30)

Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies

Arnaldos-Pérez, Cristina; Vilaseca Jolonch, Andreu; Naranjo, Laura; Sabater, Lidia; Dalmau, Josep; Ruiz-García, Raquel (Frontiers Media, 2023-05-03)

An expert patient program to improve the empowerment and quality of life of people with multiple sclerosis: protocol for a multicenter pre-post intervention study

Amil-Bujan, Paloma; Bosch, Cristina; Coll Martinez, Clàudia; AREVALO, MARIA JESUS; Anglada Clofent, Elisenda; Menéndez, Rebeca; Montalban, Xavier; Sastre Garriga, Jaume; Robles-Sánchez, Miguel Ángel (Frontiers Media, 2023-05-18)

Angiogenin in the Neurogenic Subventricular Zone After Stroke

Gabriel Salazar, Marina; Lei (Santiago), Ting; Grayston Morales, Alba; Costa Riu, Carme; Medina Gutierrez, Esperanza; Montaner Villalonga, Joan; Rosell Novel, Anna; Comabella Lopez, Manuel (Frontiers Media, 2021-06-21)

Assessing Lumbar Plexus and Sciatic Nerve Damage in Relapsing-Remitting Multiple Sclerosis Using Magnetisation Transfer Ratio

Boonsuth, Ratthaporn; Samson, Rebecca S.; Tur Gomez, Carmen; Battiston, Marco; Schneider, Torben; Grussu, Francesco (Frontiers Media, 2021-11)

Association of NEDA-4 With No Long-term Disability Progression in Multiple Sclerosis and Comparison With NEDA-3: A Systematic Review and Meta-analysis

Rotstein, Dalia; Solomon, Jacqueline; Sormani, Maria Pia; Montalban Gairín, Xavier; Ye, Xiang Y.; Dababneh, Dina (Wolters Kluwer Health, 2022-11)

Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis

Simpson-Yap, Steve; De Brouwer, Edward; Kalincik, Tomas; Rijke, Nick; Hillert, Jan A.; Walton, Clare; Zabalza de Torres, Ana; Arrambide García, Georgina (Wolters Kluwer Health, 2021-11-09)

Associations of sNfL with clinico-radiological measures in a large MS population

Sotirchos, Elias; Fitzgerald, Kathryn; Singh, Carol M.; Smith, Matthew D.; Reyes-Mantilla, Maria; Hersh, Carrie; Arrambide García, Georgina; Montalban Gairín, Xavier; Comabella Lopez, Manuel (Wiley, 2023-01)

Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data

Jones, Joanne; Vermersch, Patrick; Bass, Ann D; Boster, Aaron; Montalban Gairín, Xavier; Coles, Alasdair; Traboulsee, Anthony (SAGE Publications, 2022-04-01)

Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement

Hegen, Harald; Arrambide Garcia, Georgina; Gnanapavan, Sharmilee; Kaplan, Batia; Khalil, Michael; Saadeh, Ruba (SAGE Publications, 2023-02)

Characterisation of the safety profile of evobrutinib in over 1000 patients from phase II clinical trials in multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus: an integrated safety analysis

Montalban Gairín, Xavier; Genovese, Mark C; Parsons-Rich, Dana; Le Bolay, Claire; Kao, Amy H; Guehring, Hans; Wallace, Daniel; Tomic, Davorka Lucia (BMJ, 2023-01)

Chitinases and chitinase-like proteins as biomarkers in neurologic disorders

Pinteac, Rucsanda; Montalban Gairín, Xavier; Comabella Lopez, Manuel (Lippincott Williams & Wilkins, 2021-01)

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

Link, Jenny; Ramanujam, Ryan; Auer, Michael; Ryner, Malin; Hassler, Signe; Bachelet, Delphine; Fissolo, Nicolás Miguel; Montalban Gairín, Xavier; Comabella Lopez, Manuel (Public Library of Science, 2017-02-07)

Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method

Gold, Ralf; Barnett, Michael; Chan, Andrew; Feng, Huiyu; Fujihara, Kazuo; Giovannoni, Gavin; Montalban, Xavier; Tintore, Mar (SAGE Publications, 2023-07-14)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Browsing Centre d'Esclerosi Múltiple de Catalunya - CEMCAT by Title

A plain language summary of what clinical studies can tell us about the safety of evobrutinib – a potential treatment for multiple sclerosis

A R-Script for Generating Multiple Sclerosis Lesion Pattern Discrimination Plots

Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study

Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies

An expert patient program to improve the empowerment and quality of life of people with multiple sclerosis: protocol for a multicenter pre-post intervention study

Angiogenin in the Neurogenic Subventricular Zone After Stroke

Assessing Lumbar Plexus and Sciatic Nerve Damage in Relapsing-Remitting Multiple Sclerosis Using Magnetisation Transfer Ratio

Association of NEDA-4 With No Long-term Disability Progression in Multiple Sclerosis and Comparison With NEDA-3: A Systematic Review and Meta-analysis

Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis

Associations of sNfL with clinico-radiological measures in a large MS population

Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data

Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement

Characterisation of the safety profile of evobrutinib in over 1000 patients from phase II clinical trials in multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus: an integrated safety analysis

Chitinases and chitinase-like proteins as biomarkers in neurologic disorders

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method

Cognitive assessment in patients with multiple sclerosis: A Spanish consensus

Cognitive impairment in multiple sclerosis: diagnosis and monitoring

Consensus on early detection of disease progression in patients with multiple sclerosis

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain

Know Scientia

Guides and help

Go to...

Know Scientia

Guides and help

Go to...

Browsing Centre d'Esclerosi Múltiple de Catalunya - CEMCAT by Title

A plain language summary of what clinical studies can tell us about the safety of evobrutinib – a potential treatment for multiple sclerosis ﻿

A R-Script for Generating Multiple Sclerosis Lesion Pattern Discrimination Plots ﻿

Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study ﻿

Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies ﻿

An expert patient program to improve the empowerment and quality of life of people with multiple sclerosis: protocol for a multicenter pre-post intervention study ﻿

Angiogenin in the Neurogenic Subventricular Zone After Stroke ﻿

Assessing Lumbar Plexus and Sciatic Nerve Damage in Relapsing-Remitting Multiple Sclerosis Using Magnetisation Transfer Ratio ﻿

Association of NEDA-4 With No Long-term Disability Progression in Multiple Sclerosis and Comparison With NEDA-3: A Systematic Review and Meta-analysis ﻿

Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis ﻿

Associations of sNfL with clinico-radiological measures in a large MS population ﻿

Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data ﻿

Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement ﻿

Characterisation of the safety profile of evobrutinib in over 1000 patients from phase II clinical trials in multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus: an integrated safety analysis ﻿

Chitinases and chitinase-like proteins as biomarkers in neurologic disorders ﻿

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results ﻿

Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method ﻿

Cognitive assessment in patients with multiple sclerosis: A Spanish consensus ﻿

Cognitive impairment in multiple sclerosis: diagnosis and monitoring ﻿

Consensus on early detection of disease progression in patients with multiple sclerosis ﻿

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain ﻿

Know Scientia

Guides and help

Go to...

Know Scientia

Guides and help

Go to...

A plain language summary of what clinical studies can tell us about the safety of evobrutinib – a potential treatment for multiple sclerosis

A R-Script for Generating Multiple Sclerosis Lesion Pattern Discrimination Plots

Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study

Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies

An expert patient program to improve the empowerment and quality of life of people with multiple sclerosis: protocol for a multicenter pre-post intervention study

Angiogenin in the Neurogenic Subventricular Zone After Stroke

Assessing Lumbar Plexus and Sciatic Nerve Damage in Relapsing-Remitting Multiple Sclerosis Using Magnetisation Transfer Ratio

Association of NEDA-4 With No Long-term Disability Progression in Multiple Sclerosis and Comparison With NEDA-3: A Systematic Review and Meta-analysis

Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis

Associations of sNfL with clinico-radiological measures in a large MS population

Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data

Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement

Characterisation of the safety profile of evobrutinib in over 1000 patients from phase II clinical trials in multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus: an integrated safety analysis

Chitinases and chitinase-like proteins as biomarkers in neurologic disorders

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method

Cognitive assessment in patients with multiple sclerosis: A Spanish consensus

Cognitive impairment in multiple sclerosis: diagnosis and monitoring

Consensus on early detection of disease progression in patients with multiple sclerosis

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain